-
公开(公告)号:US10246413B2
公开(公告)日:2019-04-02
申请号:US15703056
申请日:2017-09-13
Inventor: Steffen Gaali , Felix Hausch , Alexander Kirschner , Xixi Feng , Andreas Bracher , Gerd Ruehter
IPC: C07D233/44 , A61K31/415 , C07D405/12 , C07D207/16 , C07D401/14 , C07D401/12 , C07D279/12 , C07D211/60 , C07D211/78 , C12N9/90 , G06F19/16 , C07K5/078
Abstract: The present invention relates to compounds having a selective FKBP51 ligand scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said selective FKBP51 ligand compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.
-
公开(公告)号:US10242483B2
公开(公告)日:2019-03-26
申请号:US15675893
申请日:2017-08-14
Inventor: Ali Punjani , Marcus Anthony Brubaker , David James Fleet
Abstract: A system and a method for image alignment between at least two images to a three-dimensional model. The method including: determining a lower bound and an upper bound of an acceptable likelihood of mismatch between the at least two images; evaluating the likelihood of mismatch between the at least two images over a set of poses (r), shifts (t), or both poses (r) and shifts (t); and discarding those evaluations resulting beyond the lower bound and upper bound.
-
3.
公开(公告)号:US20190087538A1
公开(公告)日:2019-03-21
申请号:US16135913
申请日:2018-09-19
Applicant: REGENERON PHARMACEUTICALS, INC.
Inventor: Wei Keat Lim
IPC: G06F19/22 , C12Q1/6886 , G06F19/16 , G06F19/12 , C12Q1/6806 , A61P35/00
Abstract: Methods for selecting a cancer patient for immunotherapy comprise establishing a total passenger gene mutation burden from a tumor of a cancer patient, generating a background distribution for the mutational burden of the tumor, normalizing the total passenger gene mutation burden against the background distribution, and categorizing the cancer patient as an immunotherapy responder when the total passenger gene mutation burden is greater than the mean of the background distribution. When the cancer patient is an immunotherapy responder, the patient may be administered an immunotherapy regimen that comprises activation/inhibition of T cell receptors that promote T cell activation and/or prolong immune cytolytic activities.
-
公开(公告)号:US10221221B2
公开(公告)日:2019-03-05
申请号:US13950239
申请日:2013-07-24
Applicant: Allele Biotechnology & Pharmaceuticals, Inc.
Inventor: Nathan C. Shaner , Gerard G. Lambert , Yuhui Ni , Jiwu Wang
IPC: A61K38/00 , C07K14/46 , G06F19/12 , G06F19/16 , C07K14/435
Abstract: The present disclosure provides isolated nucleic acid sequences encoding a monomeric green/yellow fluorescent proteins, and fragments and derivatives thereof. Also provided is a method for engineering the nucleic acid sequence, a vector comprising the nucleic acid sequence, a host cell comprising the vector, and use of the vector in a method for expressing the nucleic acid sequence. The present invention further provides an isolated nucleic acid, or mimetic or complement thereof, that hybridizes under stringent conditions to the nucleic acid sequence. Additionally, the present invention provides a monomeric green/yellow fluorescent protein encoded by the nucleic acid sequence, as well as derivatives, fragments, and homologues thereof. Also provided is an antibody that specifically binds to the green/yellow fluorescent protein.
-
公开(公告)号:US20190065677A1
公开(公告)日:2019-02-28
申请号:US16171596
申请日:2018-10-26
Applicant: Massachusetts Institute of Technology
Inventor: David K. Gifford , Haoyang Zeng , Ge Liu
Abstract: Described herein are techniques for more precisely identifying antibodies that may have a high affinity to an antigen. The techniques may be used in some embodiments for synthesizing entirely new antibodies for screening for affinity, and for more efficiently synthesizing and screening antibodies by identifying, prior to synthesis, antibodies that are predicted to have a high affinity to the antigen. In some embodiments, a machine learning engine is trained using affinity information indicating a variety of antibodies and affinity of those antibodies to an antigen. The machine learning engine may then be queried to identify an antibody predicted to have a high affinity for the antigen.
-
6.
公开(公告)号:US20190030019A1
公开(公告)日:2019-01-31
申请号:US16049708
申请日:2018-07-30
Applicant: Celgene Corporation
Inventor: Philip Chamberlain , Brian E. Cathers , Antonia Lopez-Girona
IPC: A61K31/454 , C12Q1/37 , A61K31/517 , G06F19/16
Abstract: Provided herein are compositions, therapeutic methods, screening methods, computational methods and biomarkers based upon the elucidation of the interaction among cereblon, its substrates and certain compounds or agents, including small molecules, peptides, and proteins.
-
公开(公告)号:US10183999B2
公开(公告)日:2019-01-22
申请号:US15149047
申请日:2016-05-06
Applicant: Xencor, Inc.
Inventor: Gregory Alan Lazar , Arthur J. Chirino , Wei Dang , John Desjarlais , Stephen K. Doberstein , Robert J. Hayes , Sher Bahadur Karki , Omid Vafa
IPC: C07H21/04 , C12P21/06 , C07K16/00 , C07K16/28 , C07K16/32 , A61K39/395 , C07K16/22 , C07K16/42 , C40B30/02 , G06F19/16 , G06F19/22 , C12P21/00 , G06F19/12 , A61K39/00
Abstract: The present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.
-
8.
公开(公告)号:US20180373833A1
公开(公告)日:2018-12-27
申请号:US16062075
申请日:2016-12-14
Applicant: McMaster University
Inventor: Nishanth MERWIN , Chris DEJONG , Chad JOHNSTON , Gregory CHEN , Haoxin LI , Michael SKINNIDER , McLean EDWARDS , Nathan MAGARVEY , Phil REES
Abstract: A method for linking a natural product and gene cluster is disclosed. In some embodiments, monomers of natural products are predicted from a gene sequence. In other emboidments, monomers of natural products are predicted from a chemical structure of a natural product. In another embodiment, monomers predicted from gene sequences are aligned with monomers predicted from chemical structures.
-
9.
公开(公告)号:US20180349549A1
公开(公告)日:2018-12-06
申请号:US15749384
申请日:2016-08-05
Applicant: ARES GENETICS GMBH
Inventor: ANDREAS KELLER , SUSANNE SCHMOLKE , CORD FRIEDRICH STÄHLER , CHRISTINA BACKES , VALENTINA GALATA
CPC classification number: G06F19/24 , C12Q1/689 , C12Q2600/106 , C12Q2600/156 , G06F19/18 , Y02A90/26
Abstract: Genetic resistance prediction against antimicrobial drugs in microorganism using structural changes in the genomeThe invention relates to a method of determining an infection of a patient with at least one microorganism, particularly a bacterial microorganism, potentially resistant to antimicrobial drug treatment, a method of selecting a treatment of a patient suffering from an infection with at least one microorganism, particularly bacterial microorganism, and a method of determining structural changes of the genome of the microorganism, particularly bacterial microorganism, comprising at least one gene, as well as computer program products used in these methods.
-
公开(公告)号:US20180312823A1
公开(公告)日:2018-11-01
申请号:US16030466
申请日:2018-07-09
Applicant: Eastman Chemical Company , North Carolina State University
Inventor: Stephanie Kay Clendennen , Yaroslava Georgievna Yingling , Hoshin Kim
CPC classification number: C12N9/20 , C07K2319/02 , C12P7/62 , C12P13/02 , C12P21/02 , C12Y301/01003 , G06F19/16 , G06F19/22
Abstract: The invention relates to amino acid sequence variants of a lipase with improved activity for catalyzing synthesis reactions and methods of preparing the variants. The methods include predicting amino acid sites for change based on computational models of the protein structure in non-aqueous conditions, and expressing the protein in a prokaryotic host for subsequent purification and use. The enzyme sequence variants described have a three to nine-fold improvement in synthesis activity over the parent protein sequence.
-
-
-
-
-
-
-
-
-